Communiqués InMode Ltd. Deutsche Boerse AG

Actions

154 IL0011595993

Equipement et technologie médicale avancés

Temps réel estimé Tradegate 14:02:43 06/10/2026			Varia. 5j.	Varia. 1 janv.
12,57 ^EUR	+1,49%		+1,14%	+0,44%

15/09	M.N. Business Strategy, Ltd. annule l'acquisition du solde du capital d'InMode Ltd. (NasdaqGS:INMD).	CI
09/09	InMode Ltd. annonce le lancement de Morpheus8 Cool sur la plateforme Morpheus8MAX	CI

Communiqués

02/09	D. Mass. Patent Litigation Update: July 2026	AQ
05/08	InMode: Q2 Earnings Snapshot	AQ
06/05	InMode: Q1 Earnings Snapshot	AQ
24/04	InMode Ltd. V. BTL Industries, Inc. (D. Mass. 24-cv-12955).	AQ
24/03	InMode to Present at the 25th Annual Needham Virtual Healthcare Conference	PR
13/03	InMode Announces New Share Repurchase Program	PR
10/02	Lumecca IPL in Los Angeles: Modern Photorejuvenation With Enhanced Cooling Technology	AQ
10/02	InMode : Annual Report for Fiscal Year Ending December 31, 2025 (Form 20-F)	PU
10/02	InMode: Q4 Earnings Snapshot	AQ
10/02	InMode Reports Fourth Quarter and Full Year 2025 Financial Results: Quarterly GAAP Revenue of $103.9 Million and Full Year Revenue of $370.5 Million	PR
03/02	InMode to Participate in the 13th Annual BTIG MedTech, Digital Health, Life Sciences & Diagnostics Tools Conference	PR
02/02	InMode Responds to Transaction Rumors	PR
08/01	InMode to Report Fourth Quarter & Full Year 2025 Financial Results and Hold Conference Call on February 10, 2026, Expects Q4 Revenue Between $103.6M-$103.8M	PR
05/11	InMode: Q3 Earnings Snapshot	AQ
03/11	InMode Appoints Michael Dennison as President of North America	PR
30/10/25	InMode to Participate in Upcoming Investor Conferences	PR
09/09/25	DOMA Perpetual Sends Letter Urging Board of Directors of InMode Ltd. to Return Capital to the Shareholders	PR
02/09/25	InMode to Present at Baird 2025 Global Healthcare Conference	PR
05/08/25	InMode to Participate in Upcoming Investor Conferences	PR
30/07/25	InMode: Q2 Earnings Snapshot	AQ
30/07/25	InMode Reports Second Quarter 2025 Financial Results: Quarterly Revenue of $95.6 Million, 80% Gross Margins	PR
10/07/25	InMode to Report Second Quarter 2025 Financial Results and Hold Conference Call on July 30, Expects Q2 Revenue Between $95.4M-$95.5M, Decreases Full Year 2025 Revenue Guidance to be Between $365M-$375M	PR
28/05/25	InMode Response Letter to DOMA by Moshe Mizrahy, CEO, Dated May 28, 2025	PR
20/05/25	InMode Announces Health Canada Certification of the IgniteRF Platform with the New QuantumRF Technology	AQ
16/05/25	Keys Med Spa Receives Morpheus8 Top Provider Award from Inmode	AQ